Small molecule · Agonist of alpha-1 adrenergic receptor (ADRA1A) · developed by Hikma
Phenylephrine is an alpha-1 adrenergic receptor agonist that causes vasoconstriction and increases blood pressure.
Summary written with AI from the sources listed at the end of this page.
From the indications section of the FDA label (version of Dec 26, 2024). Read the full label for the exact wording, limitations and safety information.
| Trial | Phase | Condition | Status | Sponsor |
|---|---|---|---|---|
| NCT04829799 | Phase 4 | Pain Reduction | Withdrawn | OMER |
| NCT02132312 | Phase 3 | Unilateral Cataract Extraction | Completed | OMER |
| NCT00374881 | Phase 1/2 | Acute Pain | Completed | BLRX |
Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.
Acute PainCongenital CataractPain ReductionUnilateral Cataract Extraction
Updated Oct 3, 2026.